These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 31700218)

  • 1. Head and neck cancer management and cancer stem cells implication.
    Elkashty OA; Ashry R; Tran SD
    Saudi Dent J; 2019 Oct; 31(4):395-416. PubMed ID: 31700218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A positive feedback loop involving EGFR/Akt/mTORC1 and IKK/NF-kB regulates head and neck squamous cell carcinoma proliferation.
    Li Z; Yang Z; Passaniti A; Lapidus RG; Liu X; Cullen KJ; Dan HC
    Oncotarget; 2016 May; 7(22):31892-906. PubMed ID: 26895469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines.
    Bancroft CC; Chen Z; Yeh J; Sunwoo JB; Yeh NT; Jackson S; Jackson C; Van Waes C
    Int J Cancer; 2002 Jun; 99(4):538-48. PubMed ID: 11992543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination antiangiogenic therapy and radiation in head and neck cancers.
    Hsu HW; Wall NR; Hsueh CT; Kim S; Ferris RL; Chen CS; Mirshahidi S
    Oral Oncol; 2014 Jan; 50(1):19-26. PubMed ID: 24269532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
    Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
    Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PI3K/AKT/mTOR signaling as a molecular target in head and neck cancer.
    Marquard FE; Jücker M
    Biochem Pharmacol; 2020 Feb; 172():113729. PubMed ID: 31785230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of resistance to EGFR tyrosine kinase inhibitors.
    Huang L; Fu L
    Acta Pharm Sin B; 2015 Sep; 5(5):390-401. PubMed ID: 26579470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2.
    Keysar SB; Le PN; Miller B; Jackson BC; Eagles JR; Nieto C; Kim J; Tang B; Glogowska MJ; Morton JJ; Padilla-Just N; Gomez K; Warnock E; Reisinger J; Arcaroli JJ; Messersmith WA; Wakefield LM; Gao D; Tan AC; Serracino H; Vasiliou V; Roop DR; Wang XJ; Jimeno A
    J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27634934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-targeting EGFR and IKKβ/NF-κB signalling pathways in head and neck squamous cell carcinoma: a potential novel therapy for head and neck squamous cell cancer.
    Li Z; Liao J; Yang Z; Choi EY; Lapidus RG; Liu X; Cullen KJ; Dan H
    Br J Cancer; 2019 Feb; 120(3):306-316. PubMed ID: 30585254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current challenges and clinical investigations of epidermal growth factor receptor (EGFR)- and ErbB family-targeted agents in the treatment of head and neck squamous cell carcinoma (HNSCC).
    Cohen RB
    Cancer Treat Rev; 2014 May; 40(4):567-77. PubMed ID: 24216225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of Head and Neck Squamous Cell Carcinoma Stem Cells.
    Qian X; Nie X; Wollenberg B; Sudhoff H; Kaufmann AM; Albers AE
    Adv Exp Med Biol; 2019; 1139():23-40. PubMed ID: 31134493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular landscape of head and neck cancer.
    Leemans CR; Snijders PJF; Brakenhoff RH
    Nat Rev Cancer; 2018 May; 18(5):269-282. PubMed ID: 29497144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGFR tyrosine kinase inhibitors differentially affect autophagy in head and neck squamous cell carcinoma.
    Cai J; Sun M; Ge X; Sun Y
    Biochem Biophys Res Commun; 2017 May; 486(4):1027-1033. PubMed ID: 28366635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer stem cell traits in squamospheres derived from primary head and neck squamous cell carcinomas.
    Lim YC; Oh SY; Cha YY; Kim SH; Jin X; Kim H
    Oral Oncol; 2011 Feb; 47(2):83-91. PubMed ID: 21167769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Review of HPV-Related Head and Neck Cancer.
    Kobayashi K; Hisamatsu K; Suzui N; Hara A; Tomita H; Miyazaki T
    J Clin Med; 2018 Aug; 7(9):. PubMed ID: 30150513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human epidermal growth factor receptor 3 in head and neck squamous cell carcinomas.
    Rysman B; Mouawad F; Gros A; Lansiaux A; Chevalier D; Meignan S
    Head Neck; 2016 Apr; 38 Suppl 1():E2412-8. PubMed ID: 26835877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current understanding of cancer stem cells: Review of their radiobiology and role in head and neck cancers.
    Reid PA; Wilson P; Li Y; Marcu LG; Bezak E
    Head Neck; 2017 Sep; 39(9):1920-1932. PubMed ID: 28644558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-kappaB signal pathways.
    Bancroft CC; Chen Z; Dong G; Sunwoo JB; Yeh N; Park C; Van Waes C
    Clin Cancer Res; 2001 Feb; 7(2):435-42. PubMed ID: 11234901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Head and neck squamous cell carcinoma: Genomics and emerging biomarkers for immunomodulatory cancer treatments.
    Solomon B; Young RJ; Rischin D
    Semin Cancer Biol; 2018 Oct; 52(Pt 2):228-240. PubMed ID: 29355614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSC-3436 inhibits TWIST-induced epithelial-mesenchymal transition via the suppression of Twist/Bmi1/Akt pathway in head and neck squamous cell carcinoma.
    Lai YJ; Yu WN; Kuo SC; Ho CT; Hung CM; Way TD; Chen CT
    J Cell Physiol; 2019 Jun; 234(6):9118-9129. PubMed ID: 30341909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.